CEO James Cacioppo Buys $165K of Jushi Stock at $0.51-$0.52
JUSH sits 65% above its 52-week low of $0.34.
Summary
CEO James Cacioppo bought $165K of Jushi stock at $0.51-$0.52 per share, adding to his position through One East Partners L.P.
Key Events · Ownership and Investor Activity · JUSH
-
CEO Buys $165K of Stock
James Cacioppo purchased 319,686 shares for $165,272 at $0.51-$0.52 per share on August 31 and September 1, 2026.
-
Purchase Via One East Partners L.P.
The shares were acquired indirectly through One East Partners L.P., where Cacioppo is a limited partner and the managing partner of its investment manager.
-
Insider Accumulation Trend
This purchase adds to a 90-day pattern of insider buying totaling $834,154 with no insider sales, indicating continued accumulation.
-
Post-Transaction Holdings
Cacioppo's total reported holdings after the purchase are 4,723,148 shares, including direct and indirect positions.
Analysis · JUSH · Life Sciences
CEO James Cacioppo bought 319,686 shares for $165,272 through One East Partners L.P. on August 31 and September 1 at $0.51-$0.52 per share. This is a real-money open-market purchase, not an option exercise or grant. The transaction represents roughly 0.15% of the company's market cap, which is modest in dollar terms but meaningful for a micro-cap stock trading near $0.56. Cacioppo is both CEO and a 10% owner, so his buying adds weight to the signal. The purchase follows a pattern of insider accumulation over the past 90 days, with no insider sales reported.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30.1% of the 2014 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, JUSH was trading at $0.56 on OTC in the Life Sciences sector, with a market capitalization of approximately $111.8M. The 52-week trading range was $0.34 to $0.95. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.